Latest for Corticobasal Degeneration
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial statusNo longer enrolling. Gait Analysis in Neurological Disease (Beth Israel Deaconess Medical Center)ClinicalTrials.gov
More about Corticobasal Degeneration
Clinically, patients present with asymmetric rigidity, bradykinesia, and dystonia, often affecting one limb preferentially (the affected limb becomes progressively more stiff and difficult to control). Distinctive cortical features include sensory loss, apraxia (inability to perform learned purposeful movements despite intact motor function), and the alien limb phenomenon (sensation that a limb is not under voluntary control and acts independently).
Keep reading about Corticobasal Degeneration
Cognitive decline is gradual but progressive, affecting executive function, judgment, and planning. Progressive gait disturbance and postural instability develop, with variable impact on ambulatory function. Speech difficulties including dysarthria and progressive loss of verbal output occur as disease advances. Like PSP, response to levodopa is typically poor or absent, a key diagnostic feature. Brain MRI may show asymmetric cortical atrophy.
What are the symptoms of Corticobasal Degeneration?
These are common symptoms of Corticobasal Degeneration, and how strong they are varies from person to person.
- Asymmetric parkinsonism with rigidity and bradykinesia
- Dystonia affecting affected limb
- Cortical sensory loss and apraxia
- Alien limb phenomenon
- Progressive cognitive decline
- Speech and swallowing difficulties
Who gets Corticobasal Degeneration?
Corticobasal degeneration typically presents between ages 50-70 years, with an average onset age of 64 with variable age of onset within this range. The condition affects males and females equally. Sporadic occurrence is most common, with rare familial cases reported. No ethnic predilection is evident, and CBD occurs across all populations.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
How to get help paying for Corticobasal Degeneration treatment
Charity funds and drugmaker programs for Corticobasal Degeneration, checked at the source.
- From a charity · CurePSPQuality of Life Respite Program fundOpen
Pays for: In-home respite care hours for caregivers.
The foundation says: “The Quality of Life Respite Program is now accepting applications on a rolling basis as of August 2025.”
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Corticobasal Degeneration
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Corticobasal Degeneration resources
Reputable organizations and medical references for learning more about Corticobasal Degeneration, including disease registries, foundation resources, and clinical guidelines.